ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
20.270,73
-0,39%
S&P 500
5.909,03
0,00%
Dow Jones
42.528,36
0,00%
Euro vs US Dollar
1,02965
-0,46%
Bitcoin
95.363,73
-1,59%
Pepperstone
Advertisement
Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. Vereinigtes Königreich
  5. LSE

  6. Camurus Ab (0RD1) Börsenkurse

Camurus Ab

Camurus Ab (0RD1)

LSE
101,20
0,00
( 0,00% )
Aktualisiert: 01:00:00
Verzögert um 15 Minuten

Professionelle Tools für Privatanleger.

Premium

Wichtige Statistiken und Details

Current Price
101,20
Gebot
0,00
Fragen
0,00
Volumen
185
0,00 Tagesbereich 0,00
101,20 52-Wochen-Bereich 101,20
Marktkapitalisierung
5,629B
Handelsende
101,20
Handelsbeginn
-
Letzte Trade
30
@
590
(O)
Letzter Handelszeitpunkt
12:56:54
Finanzvolumen
-
VWAP
-
Durchschnittliches Volumen (3 Mio.)
5.400
Ausgegebene Aktien
55.624.000
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
13,05
Gewinn pro Aktie (EPS)
7,76
Erlöse
1,72B
Nettogewinn
431,44M

Über Camurus Ab

Sektor
Coml Physical, Biologcl Resh
Branche
Coml Physical, Biologcl Resh
Website
www.camurus.com
Hauptsitz
Lund, Swe
Gegründet
-
Camurus Ab is listed in the Coml Physical, Biologcl Resh sector of the Londoner Börse with ticker 0RD1. The last closing price for Camurus Ab was SEK101,20. Over the last year, Camurus Ab shares have traded in a share price range of SEK 101,20 to SEK 101,20.

Camurus Ab currently has 55.624.000 shares in issue. The market capitalisation of Camurus Ab is SEK5,63 billion. Camurus Ab has a price to earnings ratio (PE ratio) of 13.05.

0RD1 Neueste Nachrichten

Weitere Nachrichten

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

17 Juli 2023
PR Newswire (US)

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly

Camurus announces new Phase 3 data reinforcing long-term safety and efficacy of octreotide SC depot (CAM2029) in patients with acromegaly PR Newswire LUND, Sweden, July 17, 2023 Favorable safety...

17 Juli 2023
PR Newswire (US)

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

24 Mai 2023
PR Newswire (US)

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder

Camurus announces FDA approval of Brixadi™ for the treatment of moderate to severe opioid use disorder PR Newswire LUND, Sweden, May 24, 2023 Brixadi is the first treatment for opioid use...

24 Mai 2023
PR Newswire (US)

Braeburn receives new Complete Response Letter for Brixadi in the US

Braeburn receives new Complete Response Letter for Brixadi in the US PR Newswire LUND, Sweden, Dec. 15, 2021 LUND, Sweden, Dec. 15, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX) today...

15 Dezember 2021
PR Newswire (US)

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease PR Newswire LUND, Sweden, Sept. 16, 2021 LUND, Sweden, Sept. 16, 2021 /PRNewswire/...

16 September 2021
PR Newswire (US)

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease

FDA grants Orphan Drug Designation in the US for CAM2029 for the treatment of polycystic liver disease PR Newswire LUND, Sweden, Sept. 16, 2021 LUND, Sweden, Sept. 16, 2021 /PRNewswire/...

16 September 2021
PR Newswire (US)

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US PR Newswire LUND, Sweden, June 26, 2021 New PDUFA action date for Brixadi set for 15 December 2021...

26 Juni 2021
PR Newswire (US)

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US

Camurus announces PDUFA date for Brixadi for the treatment of opioid use disorder in the US New PDUFA action date for Brixadi set for 15 December 2021 PR Newswire LUND, Sweden, June 26, 2021...

26 Juni 2021
PR Newswire (US)

Camurus announces Braeburn resubmits New Drug Application for Brixadi™ in the US

Camurus announces Braeburn resubmits New Drug Application for Brixadi™ in the US PR Newswire LUND, Sweden, June 15, 2021 LUND, Sweden, June 15, 2021 /PRNewswire/ -- Camurus AB (NASDAQ STO: CAMX...

16 Juni 2021
PR Newswire (US)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
100101.2101.2101.224148101.2DE
400101.2101.2101.26086101.2DE
1200101.2101.2101.25400101.2DE
2600101.2101.2101.25590101.2DE
5200101.2101.2101.215751101.2DE
15600101.2101.2101.211170101.2DE
26000101.2101.2101.27856101.2DE

0RD1 - Frequently Asked Questions (FAQ)

What is the current Camurus Ab share price?
The current share price of Camurus Ab is SEK 101,20
How many Camurus Ab shares are in issue?
Camurus Ab has 55.624.000 shares in issue
What is the market cap of Camurus Ab?
The market capitalisation of Camurus Ab is SEK 5,63B
What is the 1 year trading range for Camurus Ab share price?
Camurus Ab has traded in the range of SEK 101,20 to SEK 101,20 during the past year
What is the PE ratio of Camurus Ab?
The price to earnings ratio of Camurus Ab is 13,05
What is the cash to sales ratio of Camurus Ab?
The cash to sales ratio of Camurus Ab is 3,28
What is the reporting currency for Camurus Ab?
Camurus Ab reports financial results in SEK
What is the latest annual turnover for Camurus Ab?
The latest annual turnover of Camurus Ab is SEK 1,72B
What is the latest annual profit for Camurus Ab?
The latest annual profit of Camurus Ab is SEK 431,44M
What is the registered address of Camurus Ab?
The registered address for Camurus Ab is IDEON SCIENCE PARK, LUND, SE-223 70
What is the Camurus Ab website address?
The website address for Camurus Ab is www.camurus.com
Which industry sector does Camurus Ab operate in?
Camurus Ab operates in the COML PHYSICAL, BIOLOGCL RESH sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
GRIOGround Rents Income Fund Plc
31,50p
(37,55%)
192,95k
N4PN4 Pharma Plc
0,65p
(23,81%)
9,39M
JOGJersey Oil And Gas Plc
76,00p
(19,69%)
321,77k
ROCKRockfire Resources Plc
0,19p
(18,75%)
58,37M
MKAMkango Resources Ltd
11,00p
(18,28%)
4,59M
RBGPRbg Holdings Plc
1,25p
(-52,38%)
4,52M
PYXPyx Resources Limited
2,01p
(-22,69%)
2,72M
CHSSWorld Chess Plc
3,25p
(-18,75%)
552,58k
BORBorders & Southern Petroleum Plc
2,70p
(-16,92%)
2,32M
AGTAAgriterra Ld
0,75p
(-15,73%)
5,5k
TRPTower Resources Plc
0,0375p
(-3,85%)
445,57M
NTVONativo Resources Plc
0,0019p
(0,00%)
385,89M
GBPGlobal Petroleum Limited
0,2025p
(-7,95%)
253,35M
SYMESupply@me Capital Plc
0,0042p
(16,67%)
186,57M
DGIDg Innovate Plc
0,0185p
(-7,50%)
181,95M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

LSE
0RD1
Camurus Ab
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten